TOFACITINIB vs TOLVAPTAN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TOFACITINIB vs TOLVAPTAN: Safety Overview
| Metric | TOFACITINIB | TOLVAPTAN |
|---|---|---|
| Total FAERS Reports | 155,647 | 9,014 |
| Deaths Reported | 7,847 | 1,709 |
| Death Rate | 5.0% | 19.0% |
| Hospitalizations | 21,976 | 2,467 |
| Average Patient Age | 57.6 yrs | 56.2 yrs |
| % Female Patients | 81.6% | 52.0% |
| FDA Approval Date | Aug 19, 2021 | Apr 23, 2018 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | Otsuka America Pharmaceutical, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |